A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

Clinical trial NCT06322641 · COMPLETED

Trial details

NCT number: NCT06322641
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)Systemic Inflammation

Start date: 2024-03-26
Primary completion: 2024-05-10
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.